Medicine and Dentistry
Tamibarotene
100%
Bleomycin
50%
Macrophage Differentiation
40%
Phenotype
30%
Endothelial Cell
30%
Skin Fibrosis
30%
Systemic Scleroderma
20%
Fibrosis
20%
Fibrinogen
20%
Combination Therapy
20%
Fibroblast
20%
Intercellular Adhesion Molecule 1
20%
Skin
20%
T Cell
20%
T-Helper Cell
20%
Macrophage
20%
Transforming Growth Factor
20%
Mast Cell
10%
Lymphocyte
10%
Tumor Necrosis Factor
10%
Lymph Node
10%
Physical Disease by Body Function
10%
Cell Type
10%
Immunocompetent Cell
10%
Connective Tissue Growth Factor
10%
Monocyte Chemotactic Protein 1
10%
Development
10%
Retinoid
10%
Drug
10%
Interleukin 13
10%
Chemotherapeutic Agent
10%
Tissues
10%
Pharmacology, Toxicology and Pharmaceutical Science
Tamibarotene
100%
Bleomycin
50%
Mouse
40%
Skin Fibrosis
30%
Fibrosis
20%
Fibrinogen
20%
Intercellular Adhesion Molecule 1
20%
Systemic Sclerosis
20%
Animal
20%
Transforming Growth Factor
20%
Physical Disease by Body Function
10%
Tumor Necrosis Factor
10%
Monocyte Chemotactic Protein 1
10%
Autoimmune Disease
10%
Drug
10%
Retinoid
10%
Connective Tissue Growth Factor
10%
Inflammatory Disease
10%
Interleukin 13
10%
Immunology and Microbiology
Mouse
40%
Cells
40%
Phenotype
30%
Fibroblast
20%
Intercellular Adhesion Molecule 1
20%
Animal
20%
Systemic Scleroderma
20%
Skin
20%
Transforming Growth Factor
20%
Tumor Necrosis Factor Alpha
10%
Mast Cell
10%
Electric Potential
10%
Immunocompetent Cell
10%
Lymphocyte
10%
Inflammatory Disorder
10%
Monocyte Chemotactic Protein 1
10%
Molecule
10%
Interleukin 13
10%
Development
10%
Connective Tissue Growth Factor
10%
Tissues
10%